All posts by medical

OSU scientists replace mice genes to study vitamin Ds effects on infections – The Register-Guard

By giving mice a human gene that helps fight infections, Oregon State University scientists have made a new model to show the impacts of vitamin D on staph infections.

Research from Oregon State University has shown a new model suggesting vitamin D treatment can dramatically reduce the quantity of disease-causing bacteria in skin wounds.

OSU scientist Adrian Gombart and his collaborators in the past have examined the vitamin's role in fighting infection, but in their new study mice were given a human gene that provides a barrier against infections and is promoted by the bioactive form of vitamin D.

Mice naturally have a similar gene, but vitamin D does not trigger it. The scientists replaced the mouse gene, called Camp, with the human gene, called CAMP, which gave the mice increased resistance to gut and staph infections, caused by the bacterium Staphylococcus aureus, when vitamin D was introduced.

Vitamin D3 regulates the expression of the CAMP, and Staphylococcus aureus is an important human pathogen that causes skin infections, Gombart said in a news release. With our mouse model, we showed that treating a skin wound infected with S. aureus with the bioactive form of vitamin D significantly reduced the number of bacteria in the wound.

Vitamin D, which is fat-soluble and present in very few foods, promotes calcium absorption in the gut and is needed for bone growth. Vitamin D, manufactured by the body when triggered by sunlight, is also important for cell growth, neuromuscular function, and reduction of inflammation.

The scientists believe their new model will be useful as research into vitamin D-induced expression of CAMP progresses, involving diseases caused by microorganisms and also conditions that are non-pathogenic, such as inflammatory bowel disease.

The finding, Gombart said, suggests vitamin D can be used to increase protection against infection by increasing CAMP levels. Those findings recently were published in the Journal of Steroid Biochemistry and Molecular Biology.

Read the original:
OSU scientists replace mice genes to study vitamin Ds effects on infections - The Register-Guard

2020 Biochemistry Analyzers Market Insight ( Investment Analysis, Market Overview and Focus on Top Players) | By QYResearch – The Picayune Current

Los Angeles, United State,January 2020 :

The latest report up for sale by QY Research demonstrates that the global Biochemistry Analyzers market is likely to garner a great pace in the coming years. Analysts have scrutinized the market drivers, confinements, risks, and openings present in the overall market. The report shows course the market is expected to take in the coming years along with its estimations. The careful examination is aimed at understanding of the course of the market.

Global Biochemistry Analyzers Market: Segmentation

The global market for Biochemistry Analyzers is segmented on the basis of product, type, services, and technology. All of these segments have been studied individually. The detailed investigation allows assessment of the factors influencing the market. Experts have analyzed the nature of development, investments in research and development, changing consumption patterns, and growing number of applications. In addition, analysts have also evaluated the changing economics around the market that are likely affect its course.

Get PDF template of Biochemistry Analyzers market [emailprotected] https://www.qyresearch.com/sample-form/form/1122038/global-Biochemistry-Analyzers-market

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market includeAbbottDanaherRoche DiagnosticsSiemens

By the product type, the market is primarily split intoSemi-AutomaticFully Automatic

By the end users/application, this report covers the following segmentsHospital and Diagnostic LaboratoriesHome Care, and AcademicResearch Institutes

What will the report include?

Market Dynamics: The report shares important information on influence factors, market drivers, challenges, opportunities, and market trends as part of market dynamics.

Global Market Forecast: Readers are provided with production and revenue forecasts for the global Biochemistry Analyzers market, production and consumption forecasts for regional markets, production, revenue, and price forecasts for the global Biochemistry Analyzers market by type, and consumption forecast for the global Biochemistry Analyzers market by application.

Regional Market Analysis: It could be divided into two different sections: one for regional production analysis and the other for regional consumption analysis. Here, the analysts share gross margin, price, revenue, production, CAGR, and other factors that indicate the growth of all regional markets studied in the report.

Market Competition: In this section, the report provides information on competitive situation and trends including merger and acquisition and expansion, market shares of top three or five players, and market concentration rate. Readers could also be provided with production, revenue, and average price shares by manufacturers.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Biochemistry Analyzers market

Chapter 2: Evaluating the leading manufacturers of the global Biochemistry Analyzers market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales

Chapter 4: Presenting global Biochemistry Analyzers market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Get Customized Report in your Inbox within 24 [emailprotected] https://www.qyresearch.com/customize-request/form/1122038/global-Biochemistry-Analyzers-market

Contact US:QY Research, INC.17890 Castleton, Suite 218,Los Angeles, CA 91748USA: +1 626 295 2442China: +86 1082 945 717Japan: +81 9048 009 273India: +91 9766 478 224Emails [emailprotected]

This post was originally published on The Picayune Current

Go here to see the original:
2020 Biochemistry Analyzers Market Insight ( Investment Analysis, Market Overview and Focus on Top Players) | By QYResearch - The Picayune Current

How our phones became our whole lives in just 10 years, from a woman who resuscitates them – NBC News

When did you last put pictures in a photo album? When did you last drop off a roll of film at a drugstore, then flip through the prints an hour later? It was probably some time before the last decade given that, at the start of 2013, more than 50 percent of American adults had a smartphone for the first time, and now more than 80 percent of us do.

Since we wrapped our fingers around the first touch-screen smartphones a decade ago, the family photo album has all but ceased to exist. But even as we no longer make albums of them, we are even more obsessed with taking pictures. We spend hours transcribing our entire lives into digits inside memory chips on our phones, and maybe posting some small percentage of them online.

These photos are our lives now we can all remember every important moment in an entire year in just a few minutes by scrolling through our camera roll. If it was notable, we took a picture. For the first time ever, we can visualize an entire life, including somebody else's.

My job is to recover these pictures and videos when things go wrong sometimes very wrong. Each day, people from all over the world reach out to the iPad Rehab Microsolderings team of former stay-at-home moms (and one dad) after one of lifes most gut-wrenching moments. They are staring at a dead phone, usually a loved one's, and realizing that the data they thought or hoped was backing up, wasnt.

It is a beloved privilege to be trusted with the responsibility to recover these memories. We get to tell families every day Great news, we got the pictures back!

But what will become of these now-recovered pictures? Will they be printed, hung up and cherished, or will they rot on a USB stick never to be seen again, after the joy of the initial reunion fades? Few of us will ever really get around to loading those pictures onto the digital frame we always mean to buy. Our pictures tend to sit there on our individual phones, unseen, secure inside a tiny chip, because we are too busy spending our lives capturing newer pictures of sushi, birthday parties and sunsets you can almost see.

On a recent trip to New York City, I signed up for the sunset viewing at the top of the Rockefeller Center and, like everyone else, I took a picture. The picture I took, though, was a picture of all the people taking pictures. Some people there never did see the sun actually set they just saw the view of the sunset through their phones, held high above their heads.

At my kids' recent holiday concert, like many a parent, I quietly ignored the principals request to turn off our cellphones and just enjoy the concert. Instead, I took a picture and posted it on social media right in the middle of the concert; the caption read, I am filled with holiday joy that the six parents near me who are secretly videotaping the concert are all holding their phones in landscape mode.

It is possible we were better off when we were restricted to 24 carefully chosen shots on a tangible roll of film.

It's hard to imagine that this has all changed so much in 10 years, but it has. We suffer from a near-constant digital information overload; there is too much choice, and way too much noise. The sum of the knowledge of humanity is stuffed into our back pockets, as is access to nearly anything it can create. In the past, buying a new lawn chair would mean standing at a store and deciding between one with green woven canvas strips and one with blue. Today, it means scrolling through endless chair variations, struggling to distinguish fake reviews from genuine, and then being haunted by nagging ads stalking us everywhere we go online. Sometimes we simply give up.

Get the think newsletter.

We are part of a grand experiment: Never before have human brains been constantly exposed to the ceaseless parade of stimulation that pours from devices in our pockets.

In order to be heard above the cacophony of the internet, even our news media is forced to shout increasingly polarizing viewpoints. To deal with the sheer volume of information, our brains seek to bundle and categorize awesome or terrible and slowly lose the ability to notice and appreciate nuance. There is no longer a middle.

Through our phones, we stare into the lights of Las Vegas when we first wake up, and just before we try to sleep. How does this affect the biochemistry of our brain? We dont know for sure, but studies are already suggesting the answer is not good.

A few weeks ago, I finally decided to give it all up ... well, for one night a week. Our family started an evening of digital respite, when we turn off our phones, tablets, computers and even the television. It is just as hard as it seems, and just as amazing.

Life unplugged feels dry and brittle at first. It is painful; I dread it each week. Im dismayed to realize that feels emotionally identical to quitting smoking.

The amount of extra time, though, is phenomenal. Did you know that you can go sledding, stop by the library, make dinner and memorize all five verses of "Good King Wenceslas" before 7:00 p.m. on a Tuesday? In the second week, I laid on the bed feeling like a disgrace to my generation. What did we do with our time growing up without phones and computers? I couldnt remember. That day I spent an hour just talking with my husband about not work and not kids. When was the last time we did that?

In the third week I found myself saying yes, out of boredom, to things to which Id normally Id say no. Can we make cookies? Yes. Can we make a gingerbread house? Yes. Do you want to go cross-country skiing with me? Yes. Will you read this book with me for two solid hours tonight? Yes. Will I remember these times more than a few gigabytes of buried digital memories? Definitely.

I taught them things: We explored how to navigate without Google maps, how to live without looking up a weather forecast. They are now wholly convinced that, yes, it is indeed impossible for a human hand to break an intact egg; they know that teeth can do a fine job of it. I learned incredible details about the fabric of my childrens lives that I miss when obsessed with photo-documenting every moment.

Our phones are amazing. But we rely on them too much. We are addicted.

And, beyond that, the idea that they are helping us keep an incredible record of our lives that will persist for generations has more than a few caveats. Yes, our great-great-grandchildren will be able to get to "know" us in a way that is unprecedented if we back up our data and find ways to pass down accessing it; I'm not sure my parents' eight-tracks or boxes of slides will be so useful to my kids.

But with the increasing complexity of mobile phone security and data encryption, the ability of people like me to recover these precious memories will become more and more limited without the support of the manufacturers. Back up your data and support the right to repair, or all those pictures you're taking to show the truth of your life to your kids one day won't be worth the silicon on which they're embedded. Plus, you have to have conversations with your family or your friends about what will happen to your phone, your pictures and your entire digital footprint when you die or else large corporations and planned obsolescence will make those decisions for you in your absence.

In the meantime, though: Put your phone down. Watch a sunset. Enjoy your kid's school play as it happens. Make some cookies that exist only in your shared memories.

More from our decade reflections project:

THINKing about 2010-2019: Where we started, how we grew and where we might go

A decade of Black Lives Matter gives us a new understanding of Black liberation

College in the U.S. is at a crossroads. Will it increase social mobility or class stratification?

The success of the 'me too' movement took a decade of work, not just a hashtag

The decade in LGBTQ: Pop culture visibility but stalled political progress

Egg freezing and IVF in the 2010s brought us the next phase in women's lib

How Netflix, Star Wars and Marvel redefined Hollywood and how we experience movies

Opioids, pot and criminal justice reform helped undermine this decade's War on Drugs

Climate change became a burning issue in the past decade, but also an opportunity

Taylor Swift, Beyonc, Rihanna, Gaga, Pink and Kesha cleared the way for women in the 2010s

Celebrities like Gwyneth Paltrow made the 2010s the decade of health and wellness misinformation

White Christian America ended in the 2010s

Visit link:
How our phones became our whole lives in just 10 years, from a woman who resuscitates them - NBC News

How the fear of death affects our investment processes – MoneyWeek

Our investment impulses are driven by the knowledge that, one day, we will be dead.This article is taken from our FREE daily investment email Money Morning.

Every day, MoneyWeek's executive editor John Stepek and guest contributors explain how current economic and political developments are affecting the markets and your wealth, and give you pointers on how you can profit.

Sign up free here.

This year, I published my first book. Its called The Sceptical Investor, and its about contrarian investing or, as Ive slightly cheekily rebranded it, sceptical investing.

My publisher, Harriman House, is offering a cracking deal on the book right now. You can get 40% off by ordering it here, and entering the code SCEPTIC40 at the check-out.

If youre not convinced by that fantastic value investment, let me share an extract with you in todays Money Morning its from Chapter 5, entitled You vs the crowd.

As with any complex system, you cant model the human mind perfectly. Were a morass of conflicting, shifting desires affected by changes in both our internal environment (our own biochemistry) and our interactions with our external environment (other people, the weather, whats on the telly).

But we dont need to go into complicated models of individual minds to get a good idea of how crowds work. There are just two key impulses to wrap your head around.

Theyre commonly described as greed and fear. But Im not so keen on those labels both have very negative connotations. I prefer to say we have an expansionary impulse and a contractionary one.

When you are in an expansionary mood, your focus is on growing your wealth, grabbing a bigger piece of the cake, empire-building. When you are in contractionary mode, you want to hunker down, build walls, protect what is yours.

These two impulses are in turn driven by one simple fact: the knowledge that, one day, you will be dead.

When evolutionary psychologists and behavioural economists talk about what drives our herding instincts, they often hark back to the days when we were dwelling in Stone Age tribes out on the African savannah, at constant risk of being picked off by lions, dying of dehydration, or nibbling on some poisonous vegetation.

The idea is that we are programmed to run with the crowd because its safer. But theres more to it than a simple evolutionary hangover. You really dont have to go back to the Stone Age to find unforgiving death lurking around every corner.

Vaccines and antibiotics only became widely available to most people (in developed countries at that) in the middle of the last century.

In 1924, four years before the discovery of penicillin, the 16-year-old son of one of the most powerful men in the world US president Calvin Coolidge died of septicaemia that resulted from a blister that developed on his toe while he was playing tennis in ill-fitting shoes.

Even today, and even in the most advanced societies, life is unpredictable and full of potentially lethal threats. And while all animals have a fight or flight instinct when faced with life- threatening situations, only humans (as far as we can tell) have a sufficiently evolved brain to bless us with an ever-present awareness of the inevitability of our own extinction.

This fear may not always be at the forefront of our minds, but its never far away.

What does any fundamentally rational being crave in such an environment? Its not happiness or contentment (although these may be desirable side effects).

Its security and certainty.

I want to keep myself and my loved ones safe, and I also want to know that after I am gone, the things that I value will persist (it doesnt matter that Ill be gone at that point what matters is how I feel about that now, while Im alive).

To do that, I need to be able to do two things. I need to get out there and explore and master my environment in order to take advantage of opportunities that could make my life better and my situation more secure (the expansionary impulse).

But I also need to be highly alert to danger and ready to raise my defences in response to threats to that security (the contractionary impulse).

So how do we navigate an uncertain world? How do we impose order on the chaos around us? Its simple. We look for elements that appear to be predictable we seek patterns.

We look for cause-and-effect rules that govern outcomes and can be used to influence them. If we know (or at least think we know) that x causes y, then we can increase our level of certainty in our world view.

Some rules are governed by natural phenomenon dont fall off cliffs; dont eat poisonous mushrooms. Some are instinctive (social animals such as humans and apes have been found to have an inherent sense of fairness, even though the world itself is clearly not naturally fair).

But many of the most important ones are social (such as learning the conventions for crossing a road or transacting with one another).

And the critical point is that we dont formulate these worldviews alone. They are passed down from our parents, and reinforced by our schools, friends, co-religionists and colleagues.

In fact, historian Yuval Noah Harari, in his recent bestseller Sapiens, argues that this ability to create and believe in epic, society-spanning shared world views from religions to legal systems to money itself (which ultimately derives its value from our belief in it, and the social structures that give everyone the confidence to rely upon it) is key to our spectacular success as a species.

You can call them stories, as Harari does, or you can call them social structures, or you can think of them as rules for a particularly complicated board game.

But however you describe them, they are all systems that human beings have invented to enable us to cooperate in a more mutually bene cial way and our brains are wired to be receptive to information presented like this.

Which unfortunately, can be a real handicap in the world of investment.

Enjoyed this sample? Get the book for 40% off just enter SCEPTIC40 at the checkout.

View post:
How the fear of death affects our investment processes - MoneyWeek

Experts Reveal Beating Heart of Photosynthesis Can Help Us Meet Urgent Food Security Needs – SciTechDaily

Protein structure solved by study. Credit: University of Sheffield

Scientists have solved the structure of one of the key components of photosynthesis, a discovery that could lead to photosynthesis being redesigned to achieve higher yields and meet urgent food security needs.

The study, led by the University of Sheffield and published in the journal Nature, reveals the structure of cytochrome b6f the protein complex that significantly influences plant growth via photosynthesis.

Photosynthesis is the foundation of life on Earth providing the food, oxygen, and energy that sustains the biosphere and human civilization.

Using a high-resolution structural model, the team found that the protein complex provides the electrical connection between the two light-powered chlorophyll-proteins (Photosystems I and II) found in the plant cell chloroplast that convert sunlight into chemical energy.

Lorna Malone, the first author of the study and a Ph.D. student in the University of Sheffields Department of Molecular Biology and Biotechnology, said: Our study provides important new insights into how cytochrome b6f utilizes the electrical current passing through it to power up a proton battery. This stored energy can then be then used to make ATP, the energy currency of living cells. Ultimately this reaction provides the energy that plants need to turn carbon dioxide into the carbohydrates and biomass that sustain the global food chain.

The high-resolution structural model, determined using single-particle cryo-electron microscopy, reveals new details of the additional role of cytochrome b6f as a sensor to tune photosynthetic efficiency in response to ever-changing environmental conditions. This response mechanism protects the plant from damage during exposure to harsh conditions such as drought or excess light.

Dr. Matt Johnson, reader in Biochemistry at the University of Sheffield and one of the supervisors of the study added: Cytochrome b6f is the beating heart of photosynthesis which plays a crucial role in regulating photosynthetic efficiency.

Previous studies have shown that by manipulating the levels of this complex we can grow bigger and better plants. With the new insights we have obtained from our structure we can hope to rationally redesign photosynthesis in crop plants to achieve the higher yields we urgently need to sustain a projected global population of 9-10 billion by 2050.

###

Reference: Cryo-EM structure of the spinach cytochrome b6fcomplex at 3.6 resolution by Lorna A. Malone, Pu Qian, Guy E. Mayneord, Andrew Hitchcock, David A. Farmer, Rebecca F. Thompson, David J. K. Swainsbury, Neil A. Ranson, C. Neil Hunter and Matthew P. Johnson, 13 November 2019, Nature.DOI: 10.1038/s41586-019-1746-6

The research was conducted in collaboration with the Astbury Centre for Structural Molecular Biology at the University of Leeds.

Researchers now aim to establish how cytochrome b6f is controlled by a myriad of regulatory proteins and how these regulators affect the function of this complex.

See the original post:
Experts Reveal Beating Heart of Photosynthesis Can Help Us Meet Urgent Food Security Needs - SciTechDaily

Fruitfly Drosophilia at the heart of global conference in Pune – Hindustan Times

Prachi Bari

PUNE: Scientists from across the world who use the common fruitfly Drosophila as a model organism to address basic and applied questions in life sciences, will be participating in the 5th Asia Pacific Drosophila Research Conference (APDRC5) and Indian Drosophila Research Conference here next week.

Two Nobel laureates, Eric Wieschaus and Michael Rosbash, renowned for their work in development biology and chronobiology respectively, will be among the 100 international and 330 Indian participants in this five-day conference. It is being organised for the first time in the country by the Indian Institute of Science Education and Research (IISER).

IISERs Professor (Biology) Sutirth Dey, who is using Drosophilia for research in Ecology and Evolution said this common fruitfly is one of the most widely-used model organism in the world for research in life sciences over the last 100 years.

Its genome is entirely sequenced and there is enormous information available about its biochemistry, physiology and behaviour. That is why it is one of the most preferred model organisms in Biology, said Dey.

He noted that IISER, Pune, has a strong focus on Drosophila research with five professors and 30 PhD scholars using this organism to answer questions in developmental biology (Prof LS Shashidhara), cell biology (Prof Richa Rikhy), gene regulation and immunity (Prof Girish Ratnaparkhi) and neurobiology (Prof Aurnab Ghose).

IISER scientist and head, research communications, Shanti Kalipatnapu said, some of the biggest names in neurobiology, cell biology, developmental biology and evolutionary biology will be attending the conference. Krishnaswamy Vijay Raghavan, principal scientific adviser to the Government of India, will be one of the nine plenary speakers at the event.

Held previously in Taipei, Seoul, Beijing and Osaka, one of the highlights of this conference is that we are explicitly encouraging undergraduates from various institutes of the world to participate, said Dey.

A total of 57 talks and 240 posters covering topics such as Gametogenesisand Stem Cells, Pattern formation, Morphogenesis and Mechanobiology, Hormones and Physiology, Cellular Neurobiology, Behavioural Neurobiology, Infection and Immunity and Ecology and Evolution, will be covered in the conference.

One pre-conference symposium called Signals from the gut will be held in collaboration with the city-based National Centre for Cell Sciences (NCCS) with 70 participants.

****

Go here to read the rest:
Fruitfly Drosophilia at the heart of global conference in Pune - Hindustan Times

Mourinho: Festive schedule against every rule of physiology, biology, biochemistry – Goal.com

Tottenham have a short turnaround for their trip to Norwich City, with their manager far from happy with the Premier League fixture list

Jose Mourinho has criticised the hectic festive fixture listin the Premier League, describing it as a "crime" that clubs will be playing again on December 28.

Spurs were involved in the early kick-off on Boxing Day, rallying from a half-time deficit at home to record a hard-fought 2-1 triumph over Brighton and Hove Albion.

However, the victory came at a cost, with Harry Winks andMoussa Sissoko both picking up yellow cards that mean the duo will be suspended forSaturday's game at Norwich City.

Article continues below

Son Heung-min is also banned following his red card against Chelsea, leaving Mourinho with a lack of options -as well aslittle preparation time -for the trip to Carrow Road.

However, before his focus switched to the next game, the Portuguese took aim at the schedule.

"I cannot imagine these boys, not just my boys, but the [Graham] Potter's boys, how they can play in 48 hours," Mourinho told the media.

"If you go to control the distances they run, the intensity, the breaks, if you are going to control that and if we are going to tell anyone who understands physiology, it is a crime that they are going to play football again on the 28th.

"It is against every rule of physiology, biology, biochemistry, every rule. But that is the way it is, even with three guys suspended.

"I think from the three, two of them are unfair, Sonny unfair, Winks unfair, I can only say Sissoko had a reason for the fifth yellow card. We have to go."

Tanguy Ndombele may provide a solution to the absences inmidfield after the Frenchman was not involved against Brighton.

Mourinho clarified that while the record signing from Lyon was not injured, the player had raised concerns over his physical condition prior to the game.

"I cannot say he is injured, in five minutes we start a training session and you can go to the stands and watch it, he is going to be training normally so I cannot say he is injured," Mourinho said.

"I can say that yesterday he told me he was not feeling in condition to play the game. Not based on injuries, based on fears of previous injuries that he has had since the beginning of the season.

"Feeling not ready to start the game, but I cannot say he is injured, I can say he is not in condition to start the game, which is different."

The rest is here:
Mourinho: Festive schedule against every rule of physiology, biology, biochemistry - Goal.com

4 Trends that are Transforming the Future of Healthcare – ReadWrite

From drinking ones own urine as a cure for broken bones to blood-letting to sending electrical shocks through a persons body as a cure for mental illness healthcare has a somewhat jaded past. Fortunately, as technology has improved our ability to study human physiology, medical professionals have become increasingly adept at diagnosing and curing many different illnesses. Here are four trends that are transforming the future of healthcare.

Still, theres plenty of room for improvement to be made. Almost 20% of Americans cant afford healthcare, according to ABC News. And millions of people die from diseases like cancer and diabetes every single year.We might not ever reach immortality, but some trends can radically transform the future of healthcare in some promising ways.

In almost every industry, imaginable from gaming to every-day transportation artificial intelligence is making a big splash. And it didnt skip healthcare. One example of artificial intelligences impact on the healthcare industry is OWKIN Socrates, an AI-based technology platform created for medical professionals and their businesses.

The bot can monitor symptoms, diagnose disease, recommend treatments, and even predict outcomes, all much faster than a human can. Were probably far from being wholly dependent on artificial intelligence for medical services, but who knows what the bots will be doing next performing surgeries? Will bots be managing pharmacies? How many bots does it take to run a test? How long before bots are diagnosing disease?

One things for sure: AI is going to play a significant role in the future of healthcare the size and scope of that role are yet to be determined.

Perhaps virtual reality is having a more significant impact on healthcare than any other technological advancement. If thats the case, it would seem to be for a good reason: its working. Already, medical students are using virtual technology to learn and perform mock-surgeries. Its also being used in physical therapy to help people recover from injury or trauma.VISUALIZE reports on research that shows VR immersion for those undergoing physical therapy. VR has been used for physical therapy has also been shown to be effective in speeding up recovery time.

Overall, virtual reality is being used to calm patients, relieve pain, and adjust a patients awareness of bodily signals. The effectiveness of this tech on healthcare will likely improve as medical professionals have more time to explore its applications.

If youre disabled, a senior with low mobility, or at home alone in serious physical pain, what are you supposed to do? You cant easily drive yourself to the hospital, and calling an ambulance might be unnecessary for the symptoms youre experiencing. According to the Centers for Disease Control and Prevention, 25% of older adults fall every year, and 20% of those falls are severe.

Companies like Heal let people schedule an appointment with a licensed and certified doctor at their place of residence. Not to mention the advancements of assistive technology some of which can detect falls and automatically request immediate assistance for seniors who may have been injured due to a fall. And why not? That feels like a natural and necessary progression of the healthcare process. Some unwell people cant easily leave their home, and they shouldnt have to.

It might sound overly ambitious, but Prellis Biologics is a company thats dedicated to solving the shortage of human organs and tissues for transplantation. And theyve got at least one thing right: there is undoubtedly a shortage of organs and human tissue for transplantation. Every single day, about 20 people die waiting for a life-saving transplant that never happened. This information is according to the American Transplant Foundation.

Using laser printing technology, Prellis Biologics has managed to mimic the human cell and replicate human organs. This technology is still partly experimental, but who knows how far it will come if given a few more years or even a decade. Professionals might be able to print a new human organ as easily as prescribing medication.

All of these innovations are exciting trends but ones that still need more time to develop fully.

"Marketer to Watch" (Forbes). "Industry leader" (SAP). "Top 100 FinTech Influencer" . Tech blogger with exposure to millions. Advising startups across Europe, NYC, and Tel Aviv.

The rest is here:
4 Trends that are Transforming the Future of Healthcare - ReadWrite

Those We Lost in 2019 – The Scientist

For a complete list of our obituaries, seehere.

SYDNEY BRENNER SCIENTIFIC SYMPOSIUM

Nobel laureate Sydney Brenner died in April at the age of 92.

Brenner was best known for his discovery of sequences that stop protein translation, mRNA, and his investigation of the nematode C. elegans, which he realized would be an ideal model organism to study cell differentiation and organ development. That work won him the 2002 Nobel Prize for Physiology or Medicine.

[H]is great strength was in experiments, and in particular the choice and execution of ones that were both important and ingenious, Francis Crick, the codiscoverer of DNA who shared an office with Brenner at the MRC Laboratory of Molecular Biology (LMB) in the UK, wrote in atribute to Brenner in The Scientist in 2002.

US DEPARTMENT OF ENERGY, OAK RIDGE NATIONAL LABORATORY

American geneticist Liane Russell, famous for her work on the deleterious effects of prenatal radiation exposure and the chromosomal basis for sex determination in mammals, died in July at age 95.

She and her husband William Russell established the Oak Ridge National Laboratorys (ORNL) Mouse House, an extensive colony of mutant mice bred to model the effects of exposure to radiation.

Russells work led to a healthcare policy to ask women if they are pregnant before X-raying them and also to avoid X-rays shortly after menstruation in women of childbearing age.

Inventor of the polymerase chain reaction technique and winner of the Nobel Prize in Chemistry in 1993, Kary Mullis, died in August at age 74.

Mullis was known as a weird figure in science and a flamboyant philanderer who evangelized the use of LSD, denied the evidence for both global warming and HIV as a cause of AIDS, consulted for O.J. Simpsons legal defense, and formed a company that sold jewelry embedded with celebrities DNA, according to a 1998 profile in The Washington Post.

Mullis wrote in The Scientist in 2003 that his first attempt at PCR in 1983 was a long-shot experiment. . . . so [at midnight] I poured myself a cold Becks into a prechilled 500 ml beaker from the isotope freezer for luck, and went home. I ran a gel the next afternoon [and] stained it with ethidium. It took several months to arrive at conditions [that] would produce a convincing result.

Even still, Science and Natureboth rejected the resulting manuscript, which was ultimately published in Methods in Enzymology in 1987 and helped earn Mullis his Nobel.

Chemical engineer George Rosenkranz, the director of the pharmaceutical company that first synthesized a synthetic form of the hormone progesterone, died in June at the age of 102.

He and colleagues developed norethindrone, a synthetic version of progesterone, which was then used in the combined oral contraceptive pill and approved by the US Food and Drug Administration in 1959. The work, along with efforts in biotech, earned him many awards from scientific organizations and from the Mexican government.

Despite that, he was a very humble man, Roberto Rosenkranz, one of his sons, told the Los Angeles Times. He never was out to take credit.

Ophthalmologist and inventor Patricia Bath, whose research on lasers advanced cataract surgery, died in May at the age of 76.

During her medical internship in New York, she conducted an epidemiological study on blindness and found the rate of the condition among the black population was twice that of the white population. The finding led her to start the field of community ophthalmology, caring for underserved populations. She promoted the field by traveling to perform surgeries, training clinicians, and donating equipment.

Bath then moved to the University of California, Los Angeles, medical center in 1974 and in the 1980s began studying lasers for their potential to treat eye disorders. In 1988, she patented a device called Laserphaco Probe, which removes cataracts.

I had a few obstacles but I had to shake it off, Bath told ABC News in 2018. Hater-ation, segregation, racism, thats the noise you have to ignore that and keep your eyes focused on the prize, its just like Dr. Martin Luther King said, so thats what I did.

Nobel laureate Paul Greengard, who discovered that the brain communicates with chemical signals, died in April. He was 93.

Paul was an iconic scientist whose extraordinary seven-decade career transformed our understanding of neuroscience, Richard Lifton, president of Rockefeller University, where Greengard had been a faculty member, said in a statement. His discoveries laid out a new paradigm requiring the understanding of the biochemistry of nerve cells rather than simply their electrical activities. This work has had great impact.

Greengards work revealed how the brain uses dopamine and other chemicals to send signals from one nerve cell to another, discoveries that won him a Nobel Prize in Physiology or Medicine in 2000. Greengard used the prize money to establish an award for women doing outstanding biomedical research and named the prize after his birth mother. Drawing attention to the achievements of women working in science, he and Baylor College of Medicine professor Huda Zoghbi wrote in The Scientist in 2014, sets a powerful example for those women still dreaming of their own success.

Public health whistleblower, physician, and researcher, Shuping Wang, died in September at the age of 59.

Wangs career started in China in the 1980s, where she was a doctor and hepatitis researcher. In 1992, she was testing blood serum samples from a plasma collection station where she worked and realized that unsanitary blood collection methods had led to a hepatitis C epidemic among people who donated and received plasma at the clinic. She reported the findings to officials and was fired, the Salt Lake Tribune reported.

She took a job at the Zhoukou Health Bureau and, analyzing the blood samples there, she found 13 percent of donors had HIV and the cross-contamination there was also leading to the spread of the virus. Officials challenged her results and asked her to change the data for a report that would be sent to the provincial Department of Health. Again, she refused.

Her findings lead to the shutdown of her clinic and the establishment of HIV testing for donors. Still, roughly 1 million farmers were infected with HIV from selling their blood plasma at Chinese collection sites during the epidemic, according to The Washington Post.

In September, a few days before Wangs death, a play about her life, The King of Hells Palace, opened at Hampstead Theatre in London.

COURTESY OF RUTGERS UNIVERSITY

The developer of a widely used DNA analysis technique called shotgun sequencing, Joachim Messing, died in September. He was 73.

Jos approach to the development of his DNA sequencing tools was to spread them freely and widelythat is, he did not patent them, Robert Goodman, the executive dean of agriculture and natural resources at Rutgers University, where Messing was a faculty member, told The New York Times. He was an incredibly generous man.

His development of the DNA analysis technique and his use of it made Messing the most-cited scientist of the 1980s, according to the Institute for Scientific Information. He went on to study crop modifications, such as boosting amino acids in corn to make it more nutritious and increasing crops drought resistance.

TUFTS UNIVERSITY SCHOOL OF MEDICINE

Tufts University researcher Stuart Levy died in September at the age of 80.

Levy studied antibiotic resistance and in the 1970s showed that bacteria resistant to the drugs could move from the intestine of farm animals to farm workers, a discovery that had implications for bacterial spread in facilities such as hospitals. After Levy published his findings, other researchers started to study antibiotic resistance in hospitals.

It is hard to overstate his importance in limiting the spread of antibiotic resistance, particularly in hospital settings, Ralph Isberg, a professor of molecular biology & microbiology at Tufts, and his colleague John Leong wrote in a statement sent to The Scientist.

Neuroscientist Rahul Desikan, who developed an MRI-based map of the human cortex and identified genetic risk factors for neurogenerative diseases, died in July from amyotrophic lateral sclerosis. He was 41.

The MRI-based map, which quickly became one of the most widely-used tools in the neuroscience community, has been cited more than 4500 times, Christopher Hess, a colleague of Desikan at University of California, San Francisco, wrote in a memorial. Color figures of the atlas in its various forms still fill the pages of our leading scientific journals.

Desikan and his colleagues had just started, in 2016, what was then the largest study on the genetics of amyotrophic lateral sclerosis (ALS) when he began to experience his first symptoms the disease. He was diagnosed with ALS a few months later.

I went into medicine to take care of patients with brain diseases. Now, I have one of the diseases that I study, Desikan said in a press release earlier this year. Even with the disease, he said, he continued to find neurology fascinating and beautiful.

Ashley Yeager is an associate editor atThe Scientist. Email her at ayeager@the-scientist.com. Follow her on Twitter @AshleyJYeager.

Read the rest here:
Those We Lost in 2019 - The Scientist

He Jiankui is going to jail. Would the US criminally prosecute a rogue gene-editing researcher? – STAT

On Monday, 13 months after He Jiankui announced that he had created the worlds first gene-edited babies, the Chinese scientist was sentenced to three years in prison and fined $430,000.

Working with two embryologists, who were also sentenced to fines and imprisonment, and an unsuspecting doctor, He used in vitro fertilization to create single cell embryos, whose DNA he then altered with the gene editing tool CRISPR-Cas9 to carry a gene variant thought to confer resistance to HIV. Couples recruited for the experiment included HIV positive men, who, He reasoned, would understand the value of resistance to the virus.

Edited embryos were transferred to their intended mothers. Twin girls were born in October 2018 and, we learned yesterday, a baby girl was born in 2019.

advertisement

He Jiankui was proud of his experiment, which he deemed a success even though one of the twin girls was born with a mix of edited and unedited genes. The scientist likened his achievement to the work of Dr. Robert G. Edwards, the British physician who won the 2010 Nobel Prize in Physiology or Medicine for the development of IVF.

The international scientific community didnt see it that way. Its reaction was almost uniform condemnation. Scientific leaders called it irresponsible and premature, saying it failed to conform with international norms.

Whether the work was also a violation of Chinese law wasnt immediately clear to the international community. Several months later, however, a task force of the Health Commission of China in Guangdong Province reported that He Jiankui had violated general clinical research laws and rules, such as using a fake ethical review certificate and misleading participants about the studys risks, and also violated an ethics guidance from 2003 that barred the reproductive use of research embryos. At yesterdays sentencing, those violations were bundled together under the crime of illegal medical practice essentially practicing medicine without a license which in China carries a maximum sentence of 10 years in prison.

If He Jiankui had been a U.S. scientist, his alleged misleading of research participants and forging an ethics approval would have been considered unethical, and he would likely have been subject to sanctions from his employer, loss of research funding, and disqualification from clinical research. But the work would also have been illegal, although in a somewhat circuitous and distinctly American way.

In the 1990s and 2000s, well before the latest gene editing tools were developed but following advances in reproductive technology and completion of the human genome project, many countries passed national laws prohibiting the reproductive use of genetically modified human embryos. In the United Kingdom, which since 1990 has had one of the most developed legal frameworks for reproductive technology, transferring a genetically modified human embryo for gestation carries a penalty of up to 10 years in prison.

No directly analogous laws were ever passed in the U.S. until December 2015, when Congress included a brief 101-word provision in a budget appropriations bill that effectively outlawed human germline editing in the U.S.

The provision is a budget rider a condition of federal funding for the U.S. Food and Drug Administration. For the past four years, it has prohibited the FDA from considering any application to conduct research in which a human embryo is intentionally created or modified to include a heritable genetic modification.

The 101 words amount to a ban because the FDA has asserted jurisdiction over all clinical uses of genetically manipulated human cells. As a result, anyone planning to use gene-edited cells in humans must submit an investigational new drug (IND) application to the FDA.

If the application proposes transfusing gene-edited cells into adults with sickle cell disease or some other genetic condition as certain ongoing and proposed studies do then the FDA will consider whether to issue the application or a waiver. But if the IND application involves transferring a genetically modified human embryo for gestation even if only in one patient or one research subject the FDA is absolutely barred from even considering it.

Sanctions for proceeding without an IND application include administrative actions like disqualification by the FDA from ongoing and future research. But violations of the Federal Food, Drug and Cosmetics Act also carry criminal penalties, including fines of up to $250,000 and imprisonment for up to 10 years.

Budget riders, however, expire. Since 2015, Congress has a chance every year to alter the language in this defacto germline editing ban or remove the provision altogether and turn the question over to the FDAs regular decision-making processes. But it hasnt done this.

In the summer of 2019, the U.S. House of Representatives was urged to amend the rider to carve out from the general prohibition a procedure that aims to prevent transmission of mitochondrial disease. Although Congress ultimately left the rider unchanged, it was, apparently for the first time, openly discussed by the House Appropriations Committee. Several members called for a fuller debate of the issue, noting that the prospect of germline genome modification raises profound questions that go well beyond where the federal government should spend its money.

If and when that fuller debate occurs, American lawmakers and the American public will have a chance to engage with the scientific and ethical complexities of gene editing technologies and to consider together how best to police its use in humans.

Until then, researchers in the U.S., like He Jiankui in China, risk prison time if they attempt germline gene editing.

Josephine Johnston is director of research and research scholar at The Hastings Center, and co-editor of the book Human Flourishing in an Age of Gene Editing (Oxford University Press, 2019).

Continued here:
He Jiankui is going to jail. Would the US criminally prosecute a rogue gene-editing researcher? - STAT